Near future
No Result
View All Result
28 September 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

An injectable Novosteo drug repairs fractured bones

It injects directly into the bones and repairs them, or strengthens them, much more and much more quickly. It is a new Novosteo drug and can save lives.

February 12 2020
Gianluca RiccioGianluca Riccio
⚪ 3 minutes
Share104Pin7Tweet19SendShare5ShareShare4

READ IN:

Novosteo, startup affiliated to Purdue University is showing technology to repair bone fractures faster and with greater benefit for a patient.

One in three adults aged 60 and over who suffers from a hip fracture dies within a year. Now, a startup affiliated with Purdue University is approaching the start of clinical trials for a new injectable drug that quickly heals and repairs broken bones, and strengthens weak ones.

Novosteo bones
The image above shows fractured femurs four weeks after the fracture. The bone on the right received Novosteo's targeted injectable drug. Yellow and orange colors indicate higher density bone than purple and blue.

La discovery made at Purdue, NOV004, by Novosteo Inc. is unique in that it focuses on the fracture site while reducing exposure to the rest of the body.

Novosteo

Novosteo, the startup that develops the drug, was co-founded by the father-son team Philip S. Low e Stewart A. Low. The treatment was developed in Low's laboratory in the Purdue Institute of Drug Discovery. There are currently 288 clinical studies performed or under treatment using medical treatments developed by Purdue at 4.841 sites worldwide.

Scott Salka, who recently joined the startup as executive president, will use his 28 years of experience as an entrepreneur in the biotechnology field to help Novosteo transfer his innovations from the laboratory to clinical studies and, finally, in the hands of doctors and patients.

The article continues after the related links

RMIT: "We know how to regrow bones using sound waves"

Soon there will be 3D printed bones directly in the human body

"We have worked on some fantastic solutions with people who are truly dedicated to making a difference in reducing mortality and improving the quality of life for our aging population."Salka said. "We have completed preclinical studies with NOV004 and are looking to take it to clinical trials later this year."

Novosteo is already looking into the future use of the targeted injectable drug for other applications, including dental implants, head and face fractures, and hip and knee replacements. In addition, Novosteo has a range of drugs for the treatment of a number of musculoskeletal diseases. Salka will be showcasing some of the technology at Biocom's global life sciences partnership conference this month in La Jolla, California.

Novosteo: more strength to the bones

Novosteo was founded to reduce the morbidity, mortality and loss of productivity associated with bone fractures.

Based on the discoveries of agents that accelerate bone regeneration and innovations in methods to selectively target these agents to fractured surfaces, Novosteo has designed a series of targeted drugs.

Compounds that concentrate the healing power of the drug specifically at the fracture site, greatly speeding up and improving the healing process.

Novosteo's mission is to reduce the debilitating and often life-threatening effects of bone fractures. Will he make it?

Tags: Ossa

Latest news

  • Optivolt revolutionizes solar: efficient panels even in the shade
  • Callboats, Helsinki launches autonomous and electric taxis on water
  • China aims underground: a moon base in lava tubes
  • On Mars in 26 days with the new airbrush solar sail
  • Amazon invests in Anthropic: the AI ​​war rages on
  • Smile: Drug that regrows teeth reaches clinical trials
  • Without a brake from the institutions, will AI lead to private neo-feudalism?
  • When will we become extinct? Here comes a (nice) prediction from the supercomputer
  • DNA and longevity: how 'jumping genes' could extend our lives
  • TeddyGPT arrives, the first AI teddy bear that talks and learns with children


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Transports
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Read more
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2023 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+